Hypofibrinolytic State in Subjects with Type 2 Diabetes Mellitus Aggravated by the Metabolic Syndrome before Clinical Manifestations of Atherothrombotic Disease.

Background. Metabolic and genetic factors induce plasminogen activator inhibitor type-1 (PAI-1) overexpression; higher PAI-1 levels decrease fibrinolysis and promote atherothrombosis. Aim. To assess PAI-1 antigen levels among subjects with type 2 diabetes mellitus (T2DM) plus Metabolic Syndrome (Met...

Descripción completa

Detalles Bibliográficos

Publicado en:	BioMed Research International Vol. 2017; pp. 1 - 10
Autores principales:	Aburto-Mejía, Elsa, Santiago-Germán, David, Martínez-Marino, Manuel, María Eugenia Galván-Plata, Almeida-Gutiérrez, Eduardo, López-Alarcón, Mardia, Hernández-Juárez, Jesús, Alvarado-Moreno, Antonio, Leaños-Miranda, Alfredo, Majluf-Cruz, Abraham, Isordia-Salas, Irma
Formato:	research tables/charts Journal Article
Publicado:	Wiley-Blackwell 2/8/2017
Acceso en línea:	Ver este registro en EBSCOhost